SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lactose (India) informs about newspaper advertisement

23 Jun 2021 Evaluate

In terms of Regulation 30 and Regulation 47(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR), Lactose (India) has informed that it has attached newspaper cuttings of the advertisement in relation to the financial results for the fourth quarter and Financial Year ended on 31st March, 2021 as specified in Regulation 33 of LODR published in ‘Business Standard (English) and Vadodara Samachar (Guajarati)’ on 23rd June, 2021 and the same is also being displayed on the website of the Company: www.lactoseindialimited.com.

The above information is a part of company’s filings submitted to BSE.

Lactose India Share Price

97.88 9.00 (10.13%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×